First 100 early endometrial cancer cases treated with laparoendoscopic single-site surgery: a multicentric retrospective study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 22365037.
- Also identified by DOI 10.1016/j.ajog.2012.01.031.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We sought to assess feasibility and perioperative outcomes for laparoendoscopic single-site surgery (LESS) in early endometrial cancer. This was a retrospective multicentric study of 100 early endometrial cancer cases undergoing LESS from July 2009 through July 2011. All patients underwent total hysterectomy and bilateral salpingo-oophorectomy by LESS. Pelvic and paraaortic lymphadenectomy were performed in 48 and 27 patients, respectively. A median of 16 pelvic lymph nodes (range, 1-33) and 7 paraaortic lymph nodes (range, 2-28) were retrieved. Both median operative time (129 minutes; range, 45-321) and estimated blood loss (70 mL; range, 10-500) were greater when staging lymphadenectomy was performed (P values = .001). Four intraoperative and 4 postoperative complications were observed. Conversion to standard laparoscopy and laparotomy was necessary for completion of 1 case each. Patients responded positively regarding cosmetic result and minimal postoperative pain control. LESS further minimizes the invasive nature of surgery and is feasible for treatment of early-stage endometrial cancer.
Medical subject headings
- Endometrial Neoplasms
- Hysterectomy
- Laparoscopy